Bill Commons

OK SB 879

died on adjournment

Public health; prohibiting certain vaccination of an infant without prior written informed consent. Effective date.

Oklahoma · 2026 Regular Session · upper

Quick answers

Did OK SB 879 pass?

No. OK SB 879 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2025-02-24): Coauthored by Representative Jenkins (principal House author)

What is OK SB 879 about?

OK SB 879 is a bill in the 2026 Regular Session titled “Public health; prohibiting certain vaccination of an infant without prior written informed consent. Effective date.”.

Who sponsors OK SB 879?

Grellner, Jenkins are the primary sponsors of OK SB 879.

Introduced
2025-02-03
Latest action
2025-02-24 — Coauthored by Representative Jenkins (principal House author)
Bill type
bill
Last updated

Sponsors

  • Grellnerprimary
  • Jenkinsprimary

Committees

Not provided by source.

Action timeline

  1. 2025-02-03

    First Reading

    introduction,reading-1

  2. 2025-02-03

    Authored by Senator Grellner

  3. 2025-02-04

    Second Reading referred to Health and Human Services

    reading-2,referral-committee

  4. 2025-02-24

    Coauthored by Representative Jenkins (principal House author)

Versions

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:30:20.811026Z

Inspect retained evidence for changes recorded after evidence tracking began:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=OK&identifier=SB 879. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.